A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma
Clinical trial NCT05193214 · UNKNOWN
Trial details
- NCT number
- NCT05193214
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2023-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.